Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Forward Ventures

Founders Standish M. Fleming

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 63
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 34
Rounds per year 2.17
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.46
Exits 19
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
Summary

Forward Ventures appeared to be the VC, which was created in 1993. The leading representative office of defined VC is situated in the San Diego. The company was established in North America in United States.

The fund was created by Standish M. Fleming. The overall number of key employees were 2.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Forward Ventures, startups are often financed by Domain Associates, Gimv, Alta Partners. The meaningful sponsors for the fund in investment in the same round are Alta Partners, Gimv, Roche Venture Fund. In the next rounds fund is usually obtained by Alta Partners, Gimv, Domain Associates.

Comparing to the other companies, this Forward Ventures performs on 3 percentage points less the average number of lead investments. The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Forward Ventures the average startup value is 10-50 millions dollars. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2007. The fund is constantly included in 2-6 deals per year.

The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Tioga Pharmaceuticals, Viracta Therapeutics, Affinium Pharmaceuticals Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Forward Ventures:
Typical Co-investors
Forward Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Forward Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Xanadu

Artificial Intelligence
Big Data
Hardware
Quantum Computing
Software
$100M09 Nov 2022 Old Toronto, Ontario, Canada

TO THE MARKET

B2B
B2C
E-Commerce
Fashion
Green Consumer Goods
Manufacturing
Retail
Retail Technology
Social Entrepreneurship
Supply Chain Management
$5M05 Oct 2021 New York, New York, United States

SpotQA

Information Services
Information Technology
Mobile
Quality Assurance
Software
Web Development
$3M20 Aug 2019 London, England, United Kingdom

Viracta Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
Therapeutics
$18M04 Apr 2017 California, United States

Syndax Pharmaceuticals

Biotechnology
Clinical Trials
Drug Discovery
Pharmaceutical
$80M24 Aug 2015 Massachusetts, United States

Syndax Pharmaceuticals

Biotechnology
Clinical Trials
Drug Discovery
Pharmaceutical
$26M27 Aug 2013 Massachusetts, United States

Viracta Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
Therapeutics
$13M12 Mar 2012 California, United States

Affinium Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$15M29 Aug 2011 Austin, Texas, United States

Viracta Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
Therapeutics
$12M21 Apr 2010 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Forward Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 63
Average round size 26M
Rounds per year 2.17
Peak activity year 2007
Lead investments 4
Follow on index 0.46
Exits 19
Group Appearance index 0.98

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Xanadu

Artificial Intelligence
Big Data
Hardware
Quantum Computing
Software
$100M09 Nov 2022 Old Toronto, Ontario, Canada

TO THE MARKET

B2B
B2C
E-Commerce
Fashion
Green Consumer Goods
Manufacturing
Retail
Retail Technology
Social Entrepreneurship
Supply Chain Management
$5M05 Oct 2021 New York, New York, United States

SpotQA

Information Services
Information Technology
Mobile
Quality Assurance
Software
Web Development
$3M20 Aug 2019 London, England, United Kingdom

Viracta Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
Therapeutics
$18M04 Apr 2017 California, United States

Syndax Pharmaceuticals

Biotechnology
Clinical Trials
Drug Discovery
Pharmaceutical
$80M24 Aug 2015 Massachusetts, United States

Syndax Pharmaceuticals

Biotechnology
Clinical Trials
Drug Discovery
Pharmaceutical
$26M27 Aug 2013 Massachusetts, United States

Viracta Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
Therapeutics
$13M12 Mar 2012 California, United States

Affinium Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$15M29 Aug 2011 Austin, Texas, United States

Viracta Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
Therapeutics
$12M21 Apr 2010 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: